Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics

Read full text
Authors: Mohammad Alkhatib, Franziska M. Jakobs, John Hanson, Ashley N. Nilson, Amy E. Moritz, Tian Li, Afua B. Faibille, Lindsay A. Bourn, Peter Ramdhan, Joseph Ricchezza, Shannon Jordan, Diandra Panasis
+13 more N. V. NGUYEN, Nitish Kasarla, Bryant Wang, Sergio Sola Garcia, Julianna Saez, James Paule, Chae Bin Lee, Rana Rais, Barbara S. Slusher, David R. Sibley, Chenglong Li, Thomas M. Keck, Comfort A. Boateng
Cited by: 2
References: 69

Abstract

High Resolution Image Download MS PowerPoint Slide Dopamine D4 receptor (D 4 R) signaling affects decision-making, memory formation, cognition, and attention. Previously developed D 4 R-selective ligands were metabolically unstable in vivo due to amide bond linker hydrolysis. In this study, analog compounds were synthesized using click chemistry, bioisosterically replacing amides with a 1,2,3-triazole linker. Herein, we report 1,2,3-triazole analogs maintained high D 4 R affinity and subtype selectivity but had slightly reduced functional efficacy in cAMP and β-arrestin recruitment assays. Using rat and human liver microsomes to evaluate phase I metabolism, we determined that amide ligands were more metabolically unstable in rat microsomes, and the triazole substitutions enhanced compound stability. Four compounds were evaluated in rat pharmacokinetics studies. In particular, 17 (antagonist) and 18 (low-efficacy partial agonist) had desirable results in plasma half-life and brain exposure measures. These new analogs are suitable for behavioral studies in rats and represent improved molecular tools to further explore D 4 R signaling in rodent models.

Fields of Study & Subjects

Neurotransmitter Receptor Influence on Behavior Receptor Mechanisms and Signaling Click Chemistry and Applications

Publication details

Journal / source
ACS Pharmacology & Translational Science
Publisher
American Chemical Society (ACS)
Volume
9
Issue
2
Pages
385–403
Publication date
9 January 2026
Language
EN